EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado… - Annals of the …, 2021 - ard.bmj.com
Objectives Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …
被引用次数：47 相关文章
[PDF] scienceopen.com

[PDF][PDF] EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado, H Bertheussen… - scienceopen.com
Objectives Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado… - Annals of the …, 2021 - researchinformation.amsterdamumc …
Objectives: Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado… - Annals of the …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objectives</jats: title>< jats: p> Severe systemic inflammation
associated with some stages of COVID-19 and in fatal cases led therapeutic agents …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado… - ANNALS OF THE …, 2021 - air.uniud.it
Objectives: Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado… - Annals of the …, 2021 - discovery.ucl.ac.uk
OBJECTIVES: Severe systemic inflammation associated with some stages of COVID-19 and
in fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.

A Alunno, A Najm, PM Machado… - Annals of the …, 2021 - europepmc.org
Objectives Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado… - Annals of the …, 2021 - eprints.whiterose.ac.uk
Objectives Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

A Alunno, A Najm, PM Machado… - Annals of the …, 2021 - epub.ub.uni-muenchen.de
Objectives Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.

A Alunno, A Najm, PM Machado, H Bertheussen… - 2021 - cabidigitallibrary.org
Objectives: Severe systemic inflammation associated with some stages of COVID-19 and in
fatal cases led therapeutic agents developed or used frequently in Rheumatology being at …